Video

Jeffrey Curtis, MD: Updates to the ACR COVID-19 Vaccine Clinical Guidance

Author(s):

Chair of the ACR COVID-19 Vaccine Clinical Guidance Task Force, Jeffrey Curtis, discusses the newest vaccine recommendations amid the Omicron variant.

Last week, the American College of Rheumatology (ACR) announced its updated version of COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and Musculoskeletal Diseases.

The Chair of the ACR COVID-19 Clinical Guidance Task Force, Jeffrey Curtis, MD, MS, elaborated on the current recommendations for rheumatologists regarding third and fourth vaccine doses, booster doses, updated protocol for monoclonal antibody treatment, and treatment schedules for patients on immunosuppressant medications.

Above all else, Curtis emphasized the importance of having conversations with patients about the details of their vaccination status. He acknowledged that there's a portion of patients who are still unvaccinated, but more so, there's a population of patients who are undervaccinated, and they need guidance.

"One of the most important messages is that rheumatologists, heretofore, probably were just asking patients, have you been vaccinated?" Curtis said. "And maybe, with what? And hopefully, when? But now, it's gotten more complicated. Now it's, what dose are you on and when were you vaccinated most recently?"

From a patient perspective, a clear guideline to follow is especially crucial for some who are taking certain medications or immunosuppressant treatments since their vaccine response is likely weaker as a result.

"The rheumatology provider can then provide some counsel on when you should go get your next dose with the goal of optimizing response," he added.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.